On value-judgements and ethics in health technology assessment

The widespread application of technology in health care has imposed a broad range of challenges. The field of health technology assessment (HTA) is developed in order to face some of these challenges. However, this strategy has not been as successful as one could hope. One of the reasons for this is that social and ethical considerations have not been integrated in the HTA process. Nowadays however, such considerations have been included in many HTAs. Still, the conclusions and recommendations of the HTAs are not followed. The reason for this may be that the methods for integrating ethics for HTA are not sufficiently developed, or that they are not adequate. This article presents a supplementary approach to the ethical inquiry in HTA. It is argued that a value analysis is crucial in order to address the ethical issues of health care technology in a fruitful way and to make viable decisions about such technology.ZusammenfassungDie weit verbreitete Anwendung technischer Verfahren im Gesundheitswesen hat eine Vielfalt von Herausforderungen in den Vordergrund gerückt. Um einigen dieser Herausforderungen gegenübertreten zu können, ist das Gebiet des Health Technology Assessment (HTA, Beurteilung medizintechnischer Verfahren) entwickelt worden. Diese Strategie ist bisher jedoch nicht so erfolgreich wie man sich erhoffen könnte. Als einer der Gründe für diesen Umstand wurde früher angenommen, soziale und ethische Überlegungen seien aus dem HTA-Prozess ausgeklammert geblieben. Heute gehören jedoch gerade solche sozialen und ethischen Erwägungen zu vielen HTAs. Dennoch werden die Schlussfolgerungen und Empfehlungen der HTAs nicht befolgt. Der Grund hierfür könnte sein, dass die Ethik für HTA nicht ausreichend entwickelt ist, oder dass sie den Anforderungen von HTA nicht gerecht wird. In diesem Artikel wird ein ergänzender Ansatz zur ethischen Untersuchung im Rahmen von HTA präsentiert. Demnach ist eine Wertanalyse zwingend notwendig, um die ethischen Fragen bearbeiten zu können und zu angemessenen Entscheidungen über solche Technologien zu gelangen.RèsuméL’application largement répandue de procédés technologiques dans le domaine de la santé a mis en lumiére un grand nombre de défis. Le domaine de l’évaluation des technologies de la santé (ETS) a été développé pour maîtriser quelques uns de ces défis. Cette stratégie n’a cependant pas rencontré le succés escompté. On en vit tout d’abord la raison dans le fait que les aspects sociaux et éthiques n’avaient pas été pris en compte dans le processus d’ETS. Aujourd’hui pourtant, des considérations sociales et éthiques ont été intégrées dans de nombreuses ETS. Mais les conclusions et les recommandations des ETS ne sont toujours pas suivies. Cela s’explique peut-être par un développement insuffisant des aspects éthiques appliqués à l’ETS, ou par leur caractére inadéquat. Cet article présente une approche complémentaire des réflexions éthiques dans l’ETS. Il montre qu’une analyse des valeurs est essentielle pour aborder de maniére fructueuse les questions éthiques liées aux technologies médicales et pour déboucher sur des décisions viables sur ces technologies.

[1]  P Sundström,et al.  Interpreting the notion that technology is value-neutral , 1998, Medicine, health care, and philosophy.

[2]  G. Wilt Empirical and normative aspects of medical technology assessment. The case of reduced-size liver transplantations with living donors , 1995 .

[3]  B Hofmann,et al.  The technological invention of disease , 2001, Medical humanities.

[4]  Barbara A. Koenig,et al.  The Technological Imperative in Medical Practice: The Social Creation of a “Routine” Treatment , 1988 .

[5]  V. Miké,et al.  Perinatal Technology: Answers and Questions , 1992, The Journal of Clinical Ethics.

[6]  B. Hofmann On the value-ladenness of technology in medicine , 2001, Medicine, health care, and philosophy.

[7]  Leonhard Hennen,et al.  Biomedical and bioethical issues in Parliamentary TA and in Health Technology Assessment , 2004, Poiesis Prax..

[8]  A. Caplan How Should Values Count in the Allocation of New Technologies in Health Care , 1983 .

[9]  P. Foot The Varieties of Goodness. , 1965 .

[10]  Ortwin Renn Three decades of risk research: accomplishments and new challenges , 1998 .

[11]  Christian Clausen,et al.  Social shaping of technology in TA and HTA , 2004, Poiesis Prax..

[12]  H. Have Ethical perspectives on health technology assessment. , 2004 .

[13]  H. Have Medical technology assessment and ethics. Ambivalent relations. , 1995 .

[14]  B. Hofmann Technological assessment of intracytoplasmic sperm injection: an analysis of the value context. , 2003, Fertility and sterility.

[15]  Elias Mossialos,et al.  Health technology assessment and its influence on health-care priority setting , 2004, International Journal of Technology Assessment in Health Care.

[16]  L. Højgaard Are Health Technology Assessments a reliable tool in the analysis of the clinical value of PET in oncology? Who audits the auditors? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  G. Stent The poverty of scientism and the promise of structuralist ethics. , 1976, The Hastings Center report.

[18]  R. Gillon,et al.  Principles of health care ethics , 1995 .

[19]  D Hellerstein Overdosing on medical technology. , 1983, Technology review.

[20]  Konrad Ott,et al.  Technology assessment and ethics , 2002, Poiesis Prax..

[21]  Eric J. Cassell The sorcerer's broom. Medicine's rampant technology. , 1993, The Hastings Center report.

[22]  Christian Clausen,et al.  Ethics and HTA: some lessons and challenges for the future , 2004, Poiesis Prax..

[23]  B. Hofmann Technological medicine and the autonomy of man , 2002, Medicine, health care, and philosophy.

[24]  S Hellman,et al.  Of mice but not men. Problems of the randomized clinical trial. , 1991, The New England journal of medicine.

[25]  M. Drummond,et al.  PRIORITIZING INVESTMENTS IN HEALTH TECHNOLOGY ASSESSMENT , 2000, International Journal of Technology Assessment in Health Care.

[26]  T. Denton,et al.  Alternative Perspectives on the Biased Foundations of Medical Technology Assessment , 1993, Annals of Internal Medicine.

[27]  C. Marwick Philosophy on trial: examining ethics of clinical investigations. , 1988, JAMA.

[28]  Knut H. Sørensen,et al.  Shaping technology, guiding policy: concepts, spaces and tools , 2002 .

[29]  Introduction to the symposium: what evidence based medicine is and what it is not , 2004, Journal of Medical Ethics.

[30]  Howard Falk,et al.  The Technological Society , 1965 .

[31]  Ethics, philosophy, and evidence based medicine , 2004, Journal of Medical Ethics.

[32]  T. Nilstun,et al.  Values and technology assessmentin psychiatry , 2000, Acta psychiatrica Scandinavica. Supplementum.

[33]  Ivan Illich,et al.  Medical Nemesis: The Expropriation of Health , 1977 .

[34]  A. Faden,et al.  [Book review] medical harm, historical, conceptual, and ethical dimensions of iatrogenic illness , 1998 .

[35]  R. Ashcroft,et al.  Current epistemological problems in evidence based medicine , 2004, Journal of Medical Ethics.

[36]  I. Bross Metatechnology: A technollogy for the safe, effective, and economical use of technology , 1981 .

[37]  A. Faden,et al.  Medical Harm: Historical, Conceptual and Ethical Dimensions of Iatrogenic Illness , 1998 .

[38]  H. Banta,et al.  The ethics of assessing health technologies , 2000, Theoretical medicine and bioethics.

[39]  P. Skrabanek The death of humane medicine and the rise of coercive healthism , 1994 .

[40]  S. Blume,et al.  Technology, Science, and Obstetric Practice: The Origins and Transformation of Cephalopelvimetry , 1992 .

[41]  Laura Sampietro-Colom,et al.  SUMMARY REPORT OF THE ECHTA/ECAHI PROJECT , 2002, International Journal of Technology Assessment in Health Care.

[42]  R. Blendon,et al.  How interested are Americans in new medical technologies? A multicountry comparison. , 2001, Health affairs.

[43]  A. Grunwald,et al.  Against over-estimating the role of ethics in technology development , 2000, Science and engineering ethics.

[44]  T. Tymstra The Imperative Character of Medical Technology and the Meaning of “Anticipated Decision Regret” , 1989, International Journal of Technology Assessment in Health Care.

[45]  B. Wynne Uncertainty and environmental learning: reconceiving science and policy in the preventive paradigm. , 1992 .

[46]  L. Leibovici,et al.  Assessing ethics of trials in systematic reviews , 2004, BMJ : British Medical Journal.

[47]  Daniel Callahan,et al.  The goals of medicine : the forgotten issue in health care reform , 2000 .

[48]  Bjørn Hofmann,et al.  IS THERE A TECHNOLOGICAL IMPERATIVE IN HEALTH CARE? , 2002, International Journal of Technology Assessment in Health Care.

[49]  Bernard E. Rollin,et al.  Science and Ethics , 1943, Nature.

[50]  James Le Fanu,et al.  The Rise and Fall of Modern Medicine , 1999 .

[51]  P F de Vries Robbé,et al.  Reducing normative bias in health technology assessment: Interactive evaluation and casuistry , 1999, Medicine, health care, and philosophy.

[52]  E. Heitman,et al.  Ethical Issues in Technology Assessment: Conceptual Categories and Procedural Considerations , 1998, International Journal of Technology Assessment in Health Care.

[53]  K. Calman The ethics of allocation of scarce health care resources: a view from the centre. , 1994, Journal of medical ethics.